SCHEMBL28829

SCHEMBL28829

CCN(C)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5522835 1.00
SCHEMBL16653855 0.97
Ethyne SCHEMBL20506249 0.94
SCHEMBL31729499 0.88
SCHEMBL1975022 0.80 USP2 (0.32)
Butane SCHEMBL11540528 0.75 LMNA (0.48)
SCHEMBL12651664 0.74 ALDH1A1 (0.38)
SCHEMBL17517389 0.74
SCHEMBL9814035 0.74 TSHR (0.47)
SCHEMBL13186697 0.74 USP2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 10377 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4578857-A1 CRYPTOLEPINE SALT DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF Nankai University (CN) 2025-07-02 EP claimed
WO-2025102783-A1 CRYPTOLEPINE SALT DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 南开大学 2025-05-22 WO claimed
US-20240372141-A1 ELECTROLYTE FOR SECONDARY BATTERY AND SECONDARY BATTERY INCLUDING SAME MICROVAST, INC. 2024-11-07 US claimed
CN-118286245-A N4-hydroxycytidine and derivatives and antiviral uses related thereto 埃莫里大学 2024-07-05 CN claimed
US-20240217979-A1 GluN2 Subunit Selective Antagonists of the N-Methyl-D-Aspartate Receptors UNIV EMORY (US) 2024-07-04 US claimed
CN-118271324-A Preparation method of poncirtinib phosphate 苏州源新科技产业园有限公司 2024-07-02 CN claimed
US-20240209011-A1 HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER FLORATEK PHARMA S A (CH) 2024-06-27 US claimed
US-20240208944-A1 Quinazoline Derivatives, Pharmaceutical Compositions, and Therapeutic Uses Related to Nox Inhibition UNIV EMORY (US) 2024-06-27 US claimed
CN-118239891-A Method for preparing N- (5-pyrimidine methyl) -2-pyridine amine compound 帕潘纳(北京)科技有限公司 2024-06-25 CN claimed
US-20240197888-A1 SOS1 PROTEIN DEGRADERS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. 2024-06-20 US claimed
EP-0212353-A2 1-Aryl-5-hydrazino-pyrazoles BAYER AG (DE) 1987-03-04 EP claimed
EP-0206004-A1 E-isomers of N-alpha-(2-cyano-2-alkoxyiminoacetyl)-amino-acid derivatives and peptides BAYER AG (DE) 1986-12-30 EP claimed
EP-0205021-A2 5-Amino-4-cyano-1-pyridyl pyrazoles BAYER AG (DE) 1986-12-17 EP claimed
EP-0173821-A1 Substituted 5-amino-1-phenyl pyrazoles BAYER AG (DE) 1986-03-12 EP claimed
US-4268510-A DEMETHANIZATION, METABOLISM, RUMEN IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-05-19 US claimed
US-4267340-A BACTERICIDES; SYNTHESIS OF PENICILLINS AND CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-12 US claimed
EP-0010348-A1 Heterocyclic trichloromethyl derivatives, process for their preparation and their use IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP claimed
US-4009159-A PENICILLINS FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1977-02-22 US claimed
US-3993646-A Process for the ring expansion of penicillins to cephalosporin compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1976-11-23 US claimed
US-3980430-A CATIONIC DYE, HALOGENATED HYDROCARBON BAYER AKTIENGESELLSCHAFT (DT) 1976-09-14 US claimed